Compound ID | 1966

Update compound information

Iclaprim

Synonym(s): AR-100  |  MTF-100  |  RO-48-2622

Class: Small molecule antibacterial agent

Agent Type: Synthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-positive
Mechanism of action: Folate synthesis inhibitor. Dihydrofolate reductase inhibitor; DHFR inhibitor
Target Pathogen: Active against Gram-positive bacteria including trimethoprim-resistant strains.
Description: Synthetic compound; trimethoprim derivative; a diaminopyrimidine
Institute where first reported: Roche, Arpida, Acino Pharma, Life Sciences Management Group, Nuprim, Motif BioSciences
Year first mentioned: 2003
Highest development stage: Phase 3 (NCT02600611)
Development status: Active
Reason dropped: Shows non-inferiority
Chemical structure(s):
Click here for structure editor
Molecular weight: 354.4
Iso. SMILES: COC1=C(C2=C(C=CC(O2)C3CC3)C(=C1)CC4=CN=C(N=C4N)N)OC
InChI Key: HWJPWWYTGBZDEG-UHFFFAOYSA-N
Can. SMILES: COC1=C(C2=C(C=CC(C3CC3)O2)C(=C1)CC4=C(N)N=C(N)N=C4)OC
InChI: InChI=1S/C19H22N4O3/c1-24-15-8-11(7-12-9-22-19(21)23-18(12)20)13-5-6-14(10-3-4-10)26-16(13)17(15)25-2/h5-6,8-10,14H,3-4,7H2,1-2H3,(H4,20,21,22,23)
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/213043
Guide to Pharmacology: iclaprim
Citations:
  • https://pubmed.ncbi.nlm.nih.gov/31050628/
  • https://pubmed.ncbi.nlm.nih.gov/32081524/

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.